Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Acute Lung Injury

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Acute Lung Injury in 1 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Acute Lung Injury: A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pang, YL1
Chen, BS1
Li, SP1
Huang, CC1
Chang, SW1
Lam, CF1
Tsai, YC1

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Acute Lung Injury

ArticleYear
The preconditioning pulmonary protective effect of volatile isoflurane in acute lung injury is mediated by activation of endogenous iNOS.
    Journal of anesthesia, 2012, Volume: 26, Issue:6

    Topics: Acetylcholine; Acute Lung Injury; Amidines; Anesthetics, Inhalation; Animals; Benzylamines; Blotting

2012